Impaired declarative memory in depressed patients is slow to recover: clinical experience

Pharmacopsychiatry. 2004 Jul;37(4):147-51. doi: 10.1055/s-2004-827168.

Abstract

Introduction: The temporal course of recovery of depressed patients' cognitive impairment is not fully understood.

Methods: We used the California Verbal Learning Test (CVLT) to test declarative memory in 24 depressed patients before and after 35 days of antidepressive treatment as well as after long-term follow-up (> 12 months) in order to relate improvement of depression to recovery of cognitive impairment.

Results: Patients with complete remission after 35 days had generally been less impaired at baseline. The disturbance of declarative memory in treatment responders as well as in non-responders did not change from baseline to end of treatment (day 35). However, our results revealed normal values in the CVLT sum score as well as in measures of short- and long-delay free-recall measures in both groups after long-term full remission.

Discussion: We conclude that clinical response to antidepressive treatment precedes improvement of declarative memory. A low degree of impairment of declarative memory is associated with early complete remission of depression.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amitriptyline / administration & dosage
  • Amitriptyline / therapeutic use*
  • Antidepressive Agents, Tricyclic / administration & dosage
  • Antidepressive Agents, Tricyclic / therapeutic use*
  • Depressive Disorder, Major / diagnosis
  • Depressive Disorder, Major / drug therapy*
  • Depressive Disorder, Major / psychology*
  • Diagnostic and Statistical Manual of Mental Disorders
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • Humans
  • Hydrocortisone / analysis
  • Language Tests
  • Male
  • Memory Disorders / etiology*
  • Middle Aged
  • Paroxetine / administration & dosage
  • Paroxetine / therapeutic use*
  • Recovery of Function*
  • Remission Induction
  • Saliva / chemistry
  • Selective Serotonin Reuptake Inhibitors / administration & dosage
  • Selective Serotonin Reuptake Inhibitors / therapeutic use*
  • Severity of Illness Index
  • Surveys and Questionnaires
  • Verbal Learning

Substances

  • Antidepressive Agents, Tricyclic
  • Serotonin Uptake Inhibitors
  • Amitriptyline
  • Paroxetine
  • Hydrocortisone